NUVISAN The Science CRO
Markus Slopianka's work experience includes:
- In 2022, they were a Lab Head Discovery Bioanalysis at Nuvisan, where they managed the bioanalytical laboratory, supervised method development, coordinated interdisciplinary DMPK studies and projects, and evaluated and presented pharmaco-/toxicokinetic studies.
- From 2018 to 2022, they worked at BASF Metabolome Solutions GmbH as a Senior Laboratory Manager GLP Analytics & Metabolite Identification. In this role, they supervised a team, developed and validated analytical methods for GLP studies, and analyzed samples from experimental toxicology studies.
- From 2015 to 2017, they were a Doktorand at Bayer, where they evaluated Bile acids as Biomarkers for Liver Toxicity in Preclinical Drug Development.
- In 2014, they completed their Masterarbeit (MSc) at Bayer.
Markus Slopianka has a well-rounded education history in the field of toxicology. Markus began their academic journey in 2008 at Hochschule Fresenius Idstein, where they pursued a Bachelor of Science degree in Applied Chemistry. Markus successfully completed their undergraduate studies in 2012.
Following their Bachelor's degree, Markus further specialized in toxicology by enrolling at Charité - Universitätsmedizin Berlin. Here, they pursued a Master of Science degree in Toxicology, studying from 2012 to 2015. This master's program allowed him to delve deeper into the field and develop a solid foundation in toxicological principles.
Determined to enhance their knowledge and expertise, Markus pursued a research-oriented educational path by joining The Julius Maximilians University of Würzburg in 2015. Markus dedicated five years to complete their doctoral studies in Toxicology, and successfully obtained a Doctor of Natural Sciences (Dr. rer. nat.) degree in 2020.
Throughout their academic journey, Markus Slopianka has consistently focused on toxicology, demonstrating a clear passion and commitment to the field.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.